EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Phylogenetic Evidence of Local HIV-1 Transmission and Antiretroviral Drug Resistance in the Middle East and North Africa

Esraa Al-Fraihat, Amal Irshaid, Mohammed Sallam iD, Johan Snygg iD, Rasha Awawdeh, Hasanain Al-Shakerchi, Sama Al-Baidhani, Malik Sallam iD

Viruses · 14.08.2026 · 18 (8) · 897

DOI: 10.3390/v18080897 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, online erschienen am 14.08.2026. Verfasst von Esraa Al-Fraihat und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan. Hauptthemen laut MEDLINE: HIV-1, Phylogeny, Drug Resistance, Viral, HIV Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 195 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The molecular epidemiology and antiretroviral (ARV) drug resistance of human immunodeficiency virus type 1 (HIV-1) remain incompletely outlined in the Middle East and North Africa (MENA). The aim of this retrospective molecular epidemiology study was to analyze MENA HIV-1 sequences for phylogenetic clustering and to delineate surveillance drug-resistance mutations (SDRMs) for nucleoside reverse-transcriptase inhibitors (NRTIs), non-nucleoside reverse-transcriptase inhibitors (NNRTIs), and protease inhibitors (PIs) across various periods, locations, and subtypes/circulating recombinant forms (CRFs). Viral sequences were retrieved from the Los Alamos HIV Sequence Database as of 15 April 2026. Analyses were done using multiple sub-gene regions (two env regions (n = 224 and n = 60) and PR (n = 2413) and RT (n = 2103) of the pol gene). Phylogeny construction was conducted using maximum-likelihood estimation, while ARV drug resistance analysis was conducted using the Stanford HIVdb algorithm. The HIV-1 MENA sequences showed a remarkable genetic diversity, with co-circulation of multiple subtypes/CRFs, including subtype B in the Maghreb, Levant, and Egypt sub-regions, subtypes A1, G, CRF01_AE, and CRF02_AG in the Gulf Cooperation Council (GCC) and Yemen sub-region, and subtypes C and D in the Horn of Africa and Sudan sub-region. The percentage of MENA HIV-1 sequences in clusters was 10.3% for env1, 8.3% for env2, 22.0% for PR and 37.2% for RT. Phylogenetic reconstruction hinted at a structured epidemic dominated by small transmission units, with most clusters comprising dyads (n = 260) or networks (n = 142) and a limited number of large clusters (n = 8) that were largely confined within national boundaries, with only occasional cross-border linkages (n = 8). Overall SDRM prevalence was 3.2% in the PR region and 14.9% in the RT region, with a higher percentage of NNRTI-associated mutations (10.0%) than NRTI-associated mutations (9.1%) and dual-class resistance observed in 4.1% of sequences. Phylogenetic clustering was not associated with the probability of harboring SDRMs; however, negative binomial models showed that non-clustered sequences had a greater burden of NRTI-associated mutations, whereas no such association was observed for NNRTI- or PI-associated mutations. The findings showed predominantly localized and fragmented MENA HIV-1 transmission dynamics. Heterogeneous ARV drug resistance dynamics indicated that resistance emergence might be shaped by broader epidemiologic and treatment-related factors rather than ongoing clustered transmission. There is a need for coordinated molecular surveillance and optimized ART strategies across the MENA countries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1PhylogenyDrug Resistance, ViralHIV InfectionsHumansAfrica, NorthernMiddle EastMolecular EpidemiologyRetrospective StudiesGenetic VariationMutationGenotypeAnti-HIV Agents

Stichwörter der Autor:innen

ArabHIVantiretroviral therapygenetic diversitymolecular epidemiologyphylogenetic clusteringtransmission networks

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan.
  • Department of Clinical Laboratories and Forensic Medicine, Jordan University Hospital, Amman 11942, Jordan.
  • Department of Pharmacy, Mediclinic Parkview Hospital, Mediclinic Middle East, Dubai P.O. Box 505004, United Arab Emirates.
  • Department of Management, Mediclinic Parkview Hospital, Mediclinic Middle East, Dubai P.O. Box 505004, United Arab Emirates.
  • College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), Dubai P.O. Box 505055, United Arab Emirates.
  • Department of Management, School of Business, International American University, Los Angeles, CA 90010, USA.

ORCID-Profile: Mohammed Sallam, Johan Snygg, Malik Sallam

Zitieren

APA

Al-Fraihat, E., Irshaid, A., Sallam, M., Snygg, J., Awawdeh, R., Al-Shakerchi, H., Al-Baidhani, S., & Sallam, M. (2026). Phylogenetic Evidence of Local HIV-1 Transmission and Antiretroviral Drug Resistance in the Middle East and North Africa. Viruses, 18(8), 897. https://doi.org/10.3390/v18080897

Vancouver

Al-Fraihat E, Irshaid A, Sallam M, Snygg J, Awawdeh R, Al-Shakerchi H, et al. Phylogenetic Evidence of Local HIV-1 Transmission and Antiretroviral Drug Resistance in the Middle East and North Africa. Viruses. 2026;18(8):897. doi:10.3390/v18080897

BibTeX
@article{AlFraihat2026,
  author = {Al-Fraihat, Esraa and Irshaid, Amal and Sallam, Mohammed and Snygg, Johan and Awawdeh, Rasha and Al-Shakerchi, Hasanain and Al-Baidhani, Sama and Sallam, Malik},
  title = {Phylogenetic Evidence of Local HIV-1 Transmission and Antiretroviral Drug Resistance in the Middle East and North Africa},
  journal = {Viruses},
  year = {2026},
  volume = {18},
  number = {8},
  pages = {897},
  doi = {10.3390/v18080897}
}
Kostenlos starten →